These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15339199)

  • 1. Role of influenza vaccine for healthy children in the US.
    Block SL
    Paediatr Drugs; 2004; 6(4):199-209. PubMed ID: 15339199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.
    Piedra PA
    Semin Pediatr Infect Dis; 2002 Apr; 13(2):90-6. PubMed ID: 12122958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children.
    Gaglani MJ; Piedra PA; Herschler GB; Griffith ME; Kozinetz CA; Riggs MW; Fewlass C; Halloran ME; Longini IM; Glezen WP
    Arch Pediatr Adolesc Med; 2004 Jan; 158(1):65-73. PubMed ID: 14706961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for seasonal and pandemic influenza.
    Nichol KL; Treanor JJ
    J Infect Dis; 2006 Nov; 194 Suppl 2():S111-8. PubMed ID: 17163383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME; Piedra PA; Longini IM; Gaglani MJ; Schmotzer B; Fewlass C; Herschler GB; Glezen WP
    Vaccine; 2007 May; 25(20):4038-45. PubMed ID: 17395338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses.
    Treanor JJ; Kotloff K; Betts RF; Belshe R; Newman F; Iacuzio D; Wittes J; Bryant M
    Vaccine; 1999 Dec; 18(9-10):899-906. PubMed ID: 10580204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.
    Piedra PA; Yan L; Kotloff K; Zangwill K; Bernstein DI; King J; Treanor J; Munoz F; Wolff M; Cho I; Mendelman PM; Cordova J; Belshe RB
    Pediatrics; 2002 Oct; 110(4):662-72. PubMed ID: 12359778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seasonal influenza vaccines.
    Fiore AE; Bridges CB; Cox NJ
    Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in influenza vaccine technology: a potential new prevention strategy for employers and managed care organizations.
    Williams JP; Lednar W
    Am J Manag Care; 2002 Apr; 8(5 Suppl):S143-54. PubMed ID: 11999801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New vaccines for old diseases: trivalent cold-adapted influenza vaccine.
    Glezen WP
    Pediatr Ann; 2004 Aug; 33(8):545-50. PubMed ID: 15354606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.
    Piedra PA; Gaglani MJ; Riggs M; Herschler G; Fewlass C; Watts M; Kozinetz C; Hessel C; Glezen WP
    Pediatrics; 2005 Sep; 116(3):e397-407. PubMed ID: 16140685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
    Fiore AE; Shay DK; Haber P; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2007 Jul; 56(RR-6):1-54. PubMed ID: 17625497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.